{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:28:56Z","timestamp":1786436936603,"version":"build-2736575974"},"posted":{"date-parts":[[2026,8,11]]},"group-title":"In Review","reference-count":83,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,7,25]]},"abstract":"<title>Abstract<\/title>\n                <p>Cerebrospinal fluid (CSF) is the biofluid most proximal to the central nervous system (CNS), yet its proteomic organization across neurological disease remains unresolved. We assembled a meta-atlas of 35 CSF proteomic datasets (2016\u20132026) comprising 10,560 quality-controlled samples spanning neurodegenerative, neuroinflammatory, neuro-oncological, infectious and structural-injury contexts. Meta-analysis of cross-cohort detection defined a 747-protein core mass-spectrometry-accessible CSF proteome that generalizes to held-out cohorts. We derived thirteen consensus meta-programs that transfer across independent cohorts and span the major neural, barrier, immune and plasma compartments. Unexpectedly, these programs are dominated by a single axis of variation opposing complement- and plasma-associated inflammation against neuronal-synaptic homeostasis. This injury\u2013homeostasis axis is diagnosis-spanning and tracks clinical severity and disease activity across diverse neurological conditions. We show that a two-protein C5\u2013NRCAM model can approximate the injury\u2013homeostasis axis, bridging deep proteomic profiling toward bedside assessment.<\/p>","DOI":"10.21203\/rs.3.rs-10480838\/v1","type":"posted-content","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T07:34:31Z","timestamp":1786433671000},"source":"Crossref","is-referenced-by-count":0,"title":["A shared injury\u2013homeostasis gradient in the human CSF proteome across neurological disease"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7442-7539","authenticated-orcid":false,"given":"Alireza","family":"Mansouri","sequence":"first","affiliation":[{"name":"Penn State Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7525-0384","authenticated-orcid":false,"given":"Nicholas","family":"Mikolajewicz","sequence":"additional","affiliation":[{"name":"Terrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Riviere-Cazaux","sequence":"additional","affiliation":[{"name":"Mayo Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Tuohy","sequence":"additional","affiliation":[{"name":"Penn State Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sruthi","family":"Ranganathan","sequence":"additional","affiliation":[{"name":"Cambridge"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9671-1146","authenticated-orcid":false,"given":"Rahul","family":"Kumar","sequence":"additional","affiliation":[{"name":"Mayo Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Miller","sequence":"additional","affiliation":[{"name":"NYU"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3794-9511","authenticated-orcid":false,"given":"Manmeet","family":"Ahluwalia","sequence":"additional","affiliation":[{"name":"Baptist Health South Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0553-7520","authenticated-orcid":false,"given":"Paul","family":"Boutros","sequence":"additional","affiliation":[{"name":"Sanford Burnham Prebys Medical Discovery Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9991-7123","authenticated-orcid":false,"given":"Chetan","family":"Bettegowda","sequence":"additional","affiliation":[{"name":"John Hopkins University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Burns","sequence":"additional","affiliation":[{"name":"Mayo Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3525-5540","authenticated-orcid":false,"given":"Thomas","family":"Kislinger","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/B978-0-12-804279-3.00002-2","article-title":"The cerebrospinal fluid and barriers\u2013anatomic and physiologic considerations","volume":"146","author":"Tumani H","year":"2018","unstructured":"Tumani H, Huss A, Bachhuber F (2018) The cerebrospinal fluid and barriers\u2013anatomic and physiologic considerations. Handb Clin Neurol 146:21\u201332","journal-title":"Handb Clin Neurol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1038\/s41591-025-03831-3","article-title":"Disruption of the cerebrospinal fluid\u2013plasma protein balance in cognitive impairment and aging","volume":"31","author":"Farinas A","year":"2025","unstructured":"Farinas A et al (2025) Disruption of the cerebrospinal fluid\u2013plasma protein balance in cognitive impairment and aging. Nat Med 31:2578\u20132589","journal-title":"Nat Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e10980","DOI":"10.1371\/journal.pone.0010980","article-title":"Establishing the proteome of normal human cerebrospinal fluid","volume":"5","author":"Schutzer SE","year":"2010","unstructured":"Schutzer SE et al (2010) Establishing the proteome of normal human cerebrospinal fluid. PLoS ONE 5:e10980","journal-title":"PLoS ONE"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1074\/mcp.M114.038554","article-title":"In-depth characterization of the cerebrospinal fluid (CSF) proteome displayed through the CSF proteome resource (CSF-PR)","volume":"13","author":"Guldbrandsen A","year":"2014","unstructured":"Guldbrandsen A et al (2014) In-depth characterization of the cerebrospinal fluid (CSF) proteome displayed through the CSF proteome resource (CSF-PR). Mol Cell Proteom 13:3152\u20133163","journal-title":"Mol Cell Proteom"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1021\/acs.jproteome.8b00300","article-title":"Deep dive on the proteome of human cerebrospinal fluid: a valuable data resource for biomarker discovery and missing protein identification","volume":"17","author":"Macron C","year":"2018","unstructured":"Macron C, Lane L, N\u00fa\u00f1ez Galindo A, Dayon L (2018) Deep dive on the proteome of human cerebrospinal fluid: a valuable data resource for biomarker discovery and missing protein identification. J Proteome Res 17:4113\u20134126","journal-title":"J Proteome Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"eaaz9360","DOI":"10.1126\/sciadv.aaz9360","article-title":"Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer\u2019s disease","volume":"6","author":"Higginbotham L","year":"2020","unstructured":"Higginbotham L et al (2020) Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer\u2019s disease. Sci Adv 6:eaaz9360","journal-title":"Sci Adv"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s43587-023-00550-7","article-title":"Cerebrospinal fluid proteomics in patients with Alzheimer\u2019s disease reveals five molecular subtypes with distinct genetic risk profiles","volume":"4","author":"Tijms BM","year":"2024","unstructured":"Tijms BM et al (2024) Cerebrospinal fluid proteomics in patients with Alzheimer\u2019s disease reveals five molecular subtypes with distinct genetic risk profiles. Nat aging 4:33\u201347","journal-title":"Nat aging"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1038\/s41562-024-01924-6","article-title":"Multiplex cerebrospinal fluid proteomics identifies biomarkers for diagnosis and prediction of Alzheimer\u2019s disease","volume":"8","author":"Guo Y","year":"2024","unstructured":"Guo Y et al (2024) Multiplex cerebrospinal fluid proteomics identifies biomarkers for diagnosis and prediction of Alzheimer\u2019s disease. Nat Hum Behav 8:2047\u20132066","journal-title":"Nat Hum Behav"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.1038\/s41467-023-41122-y","article-title":"CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer s disease","volume":"14","author":"Campo M","year":"2023","unstructured":"Del Campo M et al (2023) CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer s disease. Nat Commun 14:5635","journal-title":"Nat Commun"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"6903","DOI":"10.1038\/s41467-023-42682-9","article-title":"Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis","volume":"14","author":"\u00c5kesson J","year":"2023","unstructured":"\u00c5kesson J et al (2023) Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis. Nat Commun 14:6903","journal-title":"Nat Commun"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1200\/JCO.23.01621","article-title":"Systematic review of cerebrospinal fluid biomarker discovery in neuro-oncology: a roadmap to standardization and clinical application","volume":"42","author":"Mikolajewicz N","year":"2024","unstructured":"Mikolajewicz N et al (2024) Systematic review of cerebrospinal fluid biomarker discovery in neuro-oncology: a roadmap to standardization and clinical application. J Clin Oncol 42:1961\u20131974","journal-title":"J Clin Oncol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1038\/s41467-018-06519-0","article-title":"Precisely measured protein lifetimes in the mouse brain reveal differences across tissues and subcellular fractions","volume":"9","author":"Fornasiero EF","year":"2018","unstructured":"Fornasiero EF et al (2018) Precisely measured protein lifetimes in the mouse brain reveal differences across tissues and subcellular fractions. Nat Commun 9:4230","journal-title":"Nat Commun"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.cell.2026.01.017","article-title":"Large-scale proteomics across neurological disorders uncovers biomarker panel and targets in multiple sclerosis","volume":"189","author":"Bader JM","year":"2026","unstructured":"Bader JM et al (2026) Large-scale proteomics across neurological disorders uncovers biomarker panel and targets in multiple sclerosis. Cell 189:2128\u20132147","journal-title":"Cell"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1021\/acs.jproteome.3c00366","article-title":"Deciphering protein secretion from the brain to cerebrospinal fluid for biomarker discovery","volume":"22","author":"Waury K","year":"2023","unstructured":"Waury K, de Wit R, Verberk IM, Teunissen CE, Abeln S (2023) Deciphering protein secretion from the brain to cerebrospinal fluid for biomarker discovery. J Proteome Res 22:3068\u20133080","journal-title":"J Proteome Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"eadm9654","DOI":"10.1126\/scitranslmed.adm9654","article-title":"Proteomic analysis reveals distinct cerebrospinal fluid signatures across genetic frontotemporal dementia subtypes","volume":"17","author":"Sogorb-Esteve A","year":"2025","unstructured":"Sogorb-Esteve A et al (2025) Proteomic analysis reveals distinct cerebrospinal fluid signatures across genetic frontotemporal dementia subtypes. Sci Transl Med 17:eadm9654","journal-title":"Sci Transl Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1093\/brain\/awad213","article-title":"CSF proteomics in autosomal dominant Alzheimer\u2019s disease highlights parallels with sporadic disease","volume":"146","author":"Ende EL","year":"2023","unstructured":"Van Der Ende EL et al (2023) CSF proteomics in autosomal dominant Alzheimer\u2019s disease highlights parallels with sporadic disease. Brain 146:4495\u20134507","journal-title":"Brain"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"MSB199356","DOI":"10.15252\/msb.20199356","article-title":"Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease","volume":"16","author":"Bader JM","year":"2020","unstructured":"Bader JM et al (2020) Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease. Mol Syst Biol 16:MSB199356","journal-title":"Mol Syst Biol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.aca.2014.10.009","article-title":"Bioanalytical chemistry of cytokines\u2013a review","volume":"853","author":"Stenken JA","year":"2015","unstructured":"Stenken JA, Poschenrieder AJ (2015) Bioanalytical chemistry of cytokines\u2013a review. Anal Chim Acta 853:95\u2013115","journal-title":"Anal Chim Acta"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","article-title":"Blood GFAP as an emerging biomarker in brain and spinal cord disorders","volume":"18","author":"Abdelhak A","year":"2022","unstructured":"Abdelhak A et al (2022) Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nat Reviews Neurol 18:158\u2013172","journal-title":"Nat Reviews Neurol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/s41591-025-03565-2","article-title":"A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer\u2019s disease","volume":"31","author":"Oh HS-H","year":"2025","unstructured":"Oh HS-H et al (2025) A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer\u2019s disease. Nat Med 31:1592\u20131603","journal-title":"Nat Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s43018-020-00154-9","article-title":"Gradient of developmental and injury response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity","volume":"2","author":"Richards LM","year":"2021","unstructured":"Richards LM et al (2021) Gradient of developmental and injury response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity. Nat Cancer 2:157\u2013173","journal-title":"Nat Cancer"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow SA","year":"2017","unstructured":"Liddelow SA et al (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541:481\u2013487","journal-title":"Nature"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A unique microglia type associated with restricting development of Alzheimer\u2019s disease","volume":"169","author":"Keren-Shaul H","year":"2017","unstructured":"Keren-Shaul H et al (2017) A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169:1276\u20131290","journal-title":"Cell"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuron.2025.12.012","article-title":"Reactive oligodendrocytes promote glioblastoma progression through CCL5\/CCR5-mediated glioma stem cell maintenance","volume":"114","author":"Mikolajewicz N","year":"2026","unstructured":"Mikolajewicz N et al (2026) Reactive oligodendrocytes promote glioblastoma progression through CCL5\/CCR5-mediated glioma stem cell maintenance. Neuron 114:237\u2013249","journal-title":"Neuron"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"eadt8307","DOI":"10.1126\/science.adt8307","article-title":"Epigenetic and 3D genome reprogramming during the aging of the human hippocampus","volume":"393","author":"Zemke NR","year":"2026","unstructured":"Zemke NR et al (2026) Epigenetic and 3D genome reprogramming during the aging of the human hippocampus. Science 393:eadt8307. https:\/\/doi.org:doi:10.1126\/science.adt8307","journal-title":"Science"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/ncomms2230","article-title":"Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation","volume":"3","author":"Davalos D","year":"2012","unstructured":"Davalos D et al (2012) Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. Nat Commun 3:1227","journal-title":"Nat Commun"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.neuron.2019.01.014","article-title":"Fibrinogen induces microglia-mediated spine elimination and cognitive impairment in an Alzheimer\u2019s disease model","volume":"101","author":"Merlini M","year":"2019","unstructured":"Merlini M et al (2019) Fibrinogen induces microglia-mediated spine elimination and cognitive impairment in an Alzheimer\u2019s disease model. Neuron 101:1099\u20131108","journal-title":"Neuron"},{"key":"ref28","article-title":"C5aR1\u2009+\u2009microglia exacerbate neuroinflammation and cerebral edema in acute brain injury","author":"Zhou J","year":"2026","unstructured":"Zhou J et al (2026) C5aR1\u2009+\u2009microglia exacerbate neuroinflammation and cerebral edema in acute brain injury. Neuron","journal-title":"Neuron"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"EMMM201809695","DOI":"10.15252\/emmm.201809695","article-title":"NrCAM is a marker for substrate-selective activation of ADAM10 in Alzheimer's disease","volume":"11","author":"Brummer T","year":"2019","unstructured":"Brummer T et al (2019) NrCAM is a marker for substrate-selective activation of ADAM10 in Alzheimer's disease. EMBO Mol Med 11:EMMM201809695","journal-title":"EMBO Mol Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"eadd7046","DOI":"10.1126\/science.add7046","article-title":"Transcriptomic diversity of cell types across the adult human brain","volume":"382","author":"Siletti K","year":"2023","unstructured":"Siletti K et al (2023) Transcriptomic diversity of cell types across the adult human brain. Science 382:eadd7046","journal-title":"Science"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"eaba7721","DOI":"10.1126\/science.aba7721","article-title":"A human cell atlas of fetal gene expression","volume":"370","author":"Cao J","year":"2020","unstructured":"Cao J et al (2020) A human cell atlas of fetal gene expression. Science 370:eaba7721","journal-title":"Science"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"vdaf046","DOI":"10.1093\/noajnl\/vdaf046","article-title":"Cerebrospinal fluid protein biomarkers are associated with response to multiagent intraventricular chemotherapy in patients with CNS lymphoma","volume":"7","author":"Aastha A","year":"2025","unstructured":"Aastha A et al (2025) Cerebrospinal fluid protein biomarkers are associated with response to multiagent intraventricular chemotherapy in patients with CNS lymphoma. Neuro-Oncology Adv 7:vdaf046","journal-title":"Neuro-Oncology Adv"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1717920","DOI":"10.3389\/fnmol.2026.1717920","article-title":"The Nodding syndrome cerebrospinal fluid proteome: a lens into neurodevelopmental failure consistent with environmentally triggered MECP2 dysregulation?","volume":"19","author":"Angues V","year":"2026","unstructured":"Angues V (2026) The Nodding syndrome cerebrospinal fluid proteome: a lens into neurodevelopmental failure consistent with environmentally triggered MECP2 dysregulation? Front Mol Neurosci 19:1717920","journal-title":"Front Mol Neurosci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"9322","DOI":"10.1038\/s41467-025-64903-z","article-title":"The diagnostic potential of proteomics and machine learning in Lyme neuroborreliosis","volume":"16","author":"Nielsen AB","year":"2025","unstructured":"Nielsen AB et al (2025) The diagnostic potential of proteomics and machine learning in Lyme neuroborreliosis. Nat Commun 16:9322","journal-title":"Nat Commun"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e64159","DOI":"10.7554\/eLife.64159","article-title":"Cerebrospinal fluid proteome maps detect pathogen-specific host response patterns in meningitis","volume":"10","author":"Bakochi A","year":"2021","unstructured":"Bakochi A et al (2021) Cerebrospinal fluid proteome maps detect pathogen-specific host response patterns in meningitis. Elife 10:e64159","journal-title":"Elife"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"16334","DOI":"10.1038\/s41598-018-34642-x","article-title":"Machine learning reveals protein signatures in CSF and plasma fluids of clinical value for ALS","volume":"8","author":"Bereman MS","year":"2018","unstructured":"Bereman MS, Beri J, Enders JR, Nash T (2018) Machine learning reveals protein signatures in CSF and plasma fluids of clinical value for ALS. Sci Rep 8:16334","journal-title":"Sci Rep"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1021\/acs.jproteome.2c00563","article-title":"Deep proteomics network and machine learning analysis of human cerebrospinal fluid in Japanese encephalitis virus infection","volume":"22","author":"Bharucha T","year":"2023","unstructured":"Bharucha T et al (2023) Deep proteomics network and machine learning analysis of human cerebrospinal fluid in Japanese encephalitis virus infection. J Proteome Res 22:1614\u20131629","journal-title":"J Proteome Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1038\/s41598-020-80647-w","article-title":"Potential biomarkers of childhood brain tumor identified by proteomics of cerebrospinal fluid from extraventricular drainage (EVD)","volume":"11","author":"Bruschi M","year":"2021","unstructured":"Bruschi M et al (2021) Potential biomarkers of childhood brain tumor identified by proteomics of cerebrospinal fluid from extraventricular drainage (EVD). Sci Rep 11:1818","journal-title":"Sci Rep"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e213375","DOI":"10.1212\/WNL.0000000000213375","article-title":"Unbiased CSF proteomics in patients with idiopathic normal pressure hydrocephalus to identify molecular signatures and candidate biomarkers","volume":"104","author":"Geus MB","year":"2025","unstructured":"de Geus MB et al (2025) Unbiased CSF proteomics in patients with idiopathic normal pressure hydrocephalus to identify molecular signatures and candidate biomarkers. Neurology 104:e213375","journal-title":"Neurology"},{"key":"ref40","first-page":"e200322","article-title":"Proteomics reveals age as major modifier of inflammatory CSF signatures in multiple sclerosis","volume":"12","author":"Held F","year":"2024","unstructured":"Held F et al (2024) Proteomics reveals age as major modifier of inflammatory CSF signatures in multiple sclerosis. Neurology: Neuroimmunol Neuroinflammation 12:e200322","journal-title":"Neurology: Neuroimmunol Neuroinflammation"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12014-025-09548-2","article-title":"Cerebrospinal fluid quantitative proteomic reveals potential mechanisms and biomarker candidates of children with bacterial meningitis complicated by neurological complications","volume":"22","author":"Jian B","year":"2025","unstructured":"Jian B et al (2025) Cerebrospinal fluid quantitative proteomic reveals potential mechanisms and biomarker candidates of children with bacterial meningitis complicated by neurological complications. Clin Proteomics 22:26","journal-title":"Clin Proteomics"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s43856-025-01183-0","article-title":"Unveiling proteomic and peptide-level modifications in cerebrospinal fluid and plasma in normal cognitive aging","volume":"5","author":"Kamalian A","year":"2025","unstructured":"Kamalian A et al (2025) Unveiling proteomic and peptide-level modifications in cerebrospinal fluid and plasma in normal cognitive aging. Commun Med 5:474","journal-title":"Commun Med"},{"key":"ref43","article-title":"Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson\u2019s disease","volume":"3","author":"Karayel O","year":"2022","unstructured":"Karayel O et al (2022) Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson\u2019s disease. Cell Rep Med 3","journal-title":"Cell Rep Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jprot.2018.05.012","article-title":"The human CSF pain proteome","volume":"190","author":"Khoonsari PE","year":"2019","unstructured":"Khoonsari PE et al (2019) The human CSF pain proteome. J Proteom 190:67\u201376","journal-title":"J Proteom"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"21053","DOI":"10.1038\/s41598-024-71738-z","article-title":"Proteomic profiling of cerebrospinal fluid reveals TKT as a potential biomarker for medulloblastoma","volume":"14","author":"Kim JW","year":"2024","unstructured":"Kim JW et al (2024) Proteomic profiling of cerebrospinal fluid reveals TKT as a potential biomarker for medulloblastoma. Sci Rep 14:21053","journal-title":"Sci Rep"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"vdac161","DOI":"10.1093\/noajnl\/vdac161","article-title":"Leveraging the CSF proteome toward minimally-invasive diagnostics surveillance of brain malignancies","volume":"4","author":"Mikolajewicz N","year":"2022","unstructured":"Mikolajewicz N et al (2022) Leveraging the CSF proteome toward minimally-invasive diagnostics surveillance of brain malignancies. Neuro-Oncology Adv 4:vdac161","journal-title":"Neuro-Oncology Adv"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3390\/biomedicines11051250","article-title":"Discovery of biomarkers for amyotrophic lateral sclerosis from human cerebrospinal fluid using mass-spectrometry-based proteomics","volume":"11","author":"Oh S","year":"2023","unstructured":"Oh S, Jang Y, Na CH (2023) Discovery of biomarkers for amyotrophic lateral sclerosis from human cerebrospinal fluid using mass-spectrometry-based proteomics. Biomedicines 11:1250","journal-title":"Biomedicines"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/pmic.201500284","article-title":"Label-free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis","volume":"16","author":"Opsahl JA","year":"2016","unstructured":"Opsahl JA et al (2016) Label-free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis. Proteomics 16:1154\u20131165","journal-title":"Proteomics"},{"key":"ref49","first-page":"948","article-title":"A field resource for the glioma cerebrospinal fluid proteome: Impacts of resection and location on biomarker discovery","volume":"27","author":"Riviere-Cazaux C","year":"2025","unstructured":"Riviere-Cazaux C et al (2025) A field resource for the glioma cerebrospinal fluid proteome: Impacts of resection and location on biomarker discovery. Neurooncology 27:948\u2013962","journal-title":"Neurooncology"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1800105","DOI":"10.1002\/prca.201800105","article-title":"Quantitative proteomic profiling of cerebrospinal fluid to identify candidate biomarkers for Alzheimer's disease","volume":"13","author":"Sathe G","year":"2019","unstructured":"Sathe G et al (2019) Quantitative proteomic profiling of cerebrospinal fluid to identify candidate biomarkers for Alzheimer's disease. PROTEOMICS\u2013Clinical Appl 13:1800105","journal-title":"PROTEOMICS\u2013Clinical Appl"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/jnc.15350","article-title":"Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies","volume":"158","author":"Schmid D","year":"2021","unstructured":"Schmid D et al (2021) Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies. J Neurochem 158:522\u2013538","journal-title":"J Neurochem"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"2208372","DOI":"10.1080\/07853890.2023.2208372","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome and fibromyalgia are indistinguishable by their cerebrospinal fluid proteomes","volume":"55","author":"Schutzer SE","year":"2023","unstructured":"Schutzer SE et al (2023) Myalgic encephalomyelitis\/chronic fatigue syndrome and fibromyalgia are indistinguishable by their cerebrospinal fluid proteomes. Ann Med 55:2208372","journal-title":"Ann Med"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"700031","DOI":"10.3389\/fimmu.2021.700031","article-title":"Discovery of novel biomarkers for diagnosing and predicting the progression of multiple sclerosis using TMT-based quantitative proteomics","volume":"12","author":"Shi Y","year":"2021","unstructured":"Shi Y et al (2021) Discovery of novel biomarkers for diagnosing and predicting the progression of multiple sclerosis using TMT-based quantitative proteomics. Front Immunol 12:700031","journal-title":"Front Immunol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12974-022-02654-0","article-title":"Temporal proteomics of human cerebrospinal fluid after severe traumatic brain injury","volume":"19","author":"Shultz SR","year":"2022","unstructured":"Shultz SR et al (2022) Temporal proteomics of human cerebrospinal fluid after severe traumatic brain injury. J Neuroinflamm 19:291","journal-title":"J Neuroinflamm"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"46177","DOI":"10.18632\/oncotarget.17579","article-title":"Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spread","volume":"8","author":"Spreafico F","year":"2017","unstructured":"Spreafico F et al (2017) Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spread. Oncotarget 8:46177","journal-title":"Oncotarget"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3390\/cancers16061223","article-title":"Proteomic Profiling of Cerebrospinal Fluid and Its Extracellular Vesicles from Extraventricular Drainage in Pediatric Pilocytic Astrocytoma, towards Precision Oncology","volume":"16","author":"Spinelli S","year":"2024","unstructured":"Spinelli S et al (2024) Proteomic Profiling of Cerebrospinal Fluid and Its Extracellular Vesicles from Extraventricular Drainage in Pediatric Pilocytic Astrocytoma, towards Precision Oncology. Cancers 16:1223","journal-title":"Cancers"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1700005","DOI":"10.1002\/prca.201700005","article-title":"Decreased Neuro-Axonal Proteins in CSF at First Attack of Suspected Multiple Sclerosis","volume":"11","author":"Stoop MP","year":"2017","unstructured":"Stoop MP et al (2017) Decreased Neuro-Axonal Proteins in CSF at First Attack of Suspected Multiple Sclerosis. PROTEOMICS\u2013Clinical Appl 11:1700005","journal-title":"PROTEOMICS\u2013Clinical Appl"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s13760-018-0954-4","article-title":"Identification of candidate biomarkers in converting and non-converting clinically isolated syndrome by proteomics analysis of cerebrospinal fluid","volume":"119","author":"Timirci-Kahraman O","year":"2019","unstructured":"Timirci-Kahraman O et al (2019) Identification of candidate biomarkers in converting and non-converting clinically isolated syndrome by proteomics analysis of cerebrospinal fluid. Acta Neurol Belgica 119:101\u2013111","journal-title":"Acta Neurol Belgica"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/acn3.51890","article-title":"Proteomics and mathematical modeling of longitudinal CSF differentiates fast versus slow ALS progression","volume":"10","author":"Vu L","year":"2023","unstructured":"Vu L et al (2023) Proteomics and mathematical modeling of longitudinal CSF differentiates fast versus slow ALS progression. Ann Clin Transl Neurol 10:2025\u20132042","journal-title":"Ann Clin Transl Neurol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1038\/s41598-021-81279-4","article-title":"A comparative study of evaluating missing value imputation methods in label-free proteomics","volume":"11","author":"Jin L","year":"2021","unstructured":"Jin L et al (2021) A comparative study of evaluating missing value imputation methods in label-free proteomics. Sci Rep 11:1760","journal-title":"Sci Rep"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods","volume":"8","author":"Johnson WE","year":"2007","unstructured":"Johnson WE, Li C, Rabinovic A (2007) Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8:118\u2013127","journal-title":"Biostatistics"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie ME","year":"2015","unstructured":"Ritchie ME et al (2015) limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43:e47\u2013e47","journal-title":"Nucleic Acids Res"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1092341","DOI":"10.3389\/fsysb.2023.1092341","article-title":"Batch correction and harmonization of\u2013Omics datasets with a tunable median polish of ratio","volume":"3","author":"Dammer EB","year":"2023","unstructured":"Dammer EB, Seyfried NT, Johnson EC (2023) Batch correction and harmonization of\u2013Omics datasets with a tunable median polish of ratio. Front Syst biology 3:1092341","journal-title":"Front Syst biology"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"7104","DOI":"10.1038\/s41467-025-62237-4","article-title":"High performance data integration for large-scale analyses of incomplete Omic profiles using Batch-Effect Reduction Trees (BERT)","volume":"16","author":"Schumann Y","year":"2025","unstructured":"Schumann Y, Schlumbohm S, Neumann JE, Neumann P (2025) High performance data integration for large-scale analyses of incomplete Omic profiles using Batch-Effect Reduction Trees (BERT). Nat Commun 16:7104","journal-title":"Nat Commun"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41592-018-0254-1","article-title":"J. A test metric for assessing single-cell RNA-seq batch correction","volume":"16","author":"B\u00fcttner M","year":"2019","unstructured":"B\u00fcttner M, Miao Z, Wolf FA, Teichmann SA, Theis F (2019) J. A test metric for assessing single-cell RNA-seq batch correction. Nat Methods 16:43\u201349","journal-title":"Nat Methods"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n M","year":"2015","unstructured":"Uhl\u00e9n M et al (2015) Tissue-based map of the human proteome. Science 347:1260419","journal-title":"Science"},{"key":"ref67","author":"Palasca O","year":"2018","unstructured":"Palasca O, Santos A, Stolte C, Gorodkin J, Jensen LJ (2018) TISSUES 2.0: an integrative web resource on mammalian tissue expression. Database bay003 (2018)"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"D870","DOI":"10.1093\/nar\/gkac947","article-title":"CellMarker 2.0: an updated database of manually curated cell markers in human\/mouse and web tools based on scRNA-seq data","volume":"51","author":"Hu C","year":"2023","unstructured":"Hu C et al (2023) CellMarker 2.0: an updated database of manually curated cell markers in human\/mouse and web tools based on scRNA-seq data. Nucleic Acids Res 51:D870\u2013D876","journal-title":"Nucleic Acids Res"},{"key":"ref69","author":"Franz\u00e9n O","year":"2019","unstructured":"Franz\u00e9n O, Gan L-M, Bj\u00f6rkegren JL (2019) PanglaoDB: a web server for exploration of mouse and human single-cell RNA sequencing data. Database baz046 (2019)"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"W215","DOI":"10.1093\/nar\/gkae237","article-title":"DeepLoc 2.1: multi-label membrane protein type prediction using protein language models","volume":"52","author":"\u00d8dum MT","year":"2024","unstructured":"\u00d8dum MT et al (2024) DeepLoc 2.1: multi-label membrane protein type prediction using protein language models. Nucleic Acids Res 52:W215\u2013W220","journal-title":"Nucleic Acids Res"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"D652","DOI":"10.1093\/nar\/gkaf1126","article-title":"OmniPath: integrated knowledgebase for multi-omics analysis","volume":"54","author":"T\u00fcrei D","year":"2026","unstructured":"T\u00fcrei D et al (2026) OmniPath: integrated knowledgebase for multi-omics analysis. Nucleic Acids Res 54:D652\u2013D660","journal-title":"Nucleic Acids Res"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"D235","DOI":"10.1093\/nar\/gkq830","article-title":"MatrixDB, the extracellular matrix interaction database","volume":"39","author":"Chautard E","year":"2010","unstructured":"Chautard E, Fatoux-Ardore M, Ballut L, Thierry-Mieg N, Ricard-Blum S (2010) MatrixDB, the extracellular matrix interaction database. Nucleic Acids Res 39:D235\u2013D240","journal-title":"Nucleic Acids Res"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"a004903","DOI":"10.1101\/cshperspect.a004903","article-title":"Overview of the matrisome\u2014an inventory of extracellular matrix constituents and functions","volume":"4","author":"Hynes RO","year":"2012","unstructured":"Hynes RO, Naba A (2012) Overview of the matrisome\u2014an inventory of extracellular matrix constituents and functions. Cold Spring Harb Perspect Biol 4:a004903","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/s41587-021-01156-3","article-title":"SignalP 6.0 predicts all five types of signal peptides using protein language models","volume":"40","author":"Teufel F","year":"2022","unstructured":"Teufel F et al (2022) SignalP 6.0 predicts all five types of signal peptides using protein language models. Nat Biotechnol 40:1023\u20131025","journal-title":"Nat Biotechnol"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"2050017","DOI":"10.1142\/S0219720020500171","article-title":"A deep learning model for predicting the ectodomain shedding events of membrane proteins","volume":"18","author":"Cao Z","year":"2020","unstructured":"Cao Z, Du W, Li G, Cao H, DEEPSMP (2020) A deep learning model for predicting the ectodomain shedding events of membrane proteins. J Bioinform Comput Biol 18:2050017","journal-title":"J Bioinform Comput Biol"},{"key":"ref76","author":"Huang W-Y","year":"2023","unstructured":"Huang W-Y, Wu K-PSDB (2023) : a revision of an ectodomain shedding database based on a comprehensive literature review and online resources. Journal of proteome research 22, 2570\u20132576 (2023)"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/bioinformatics\/bty786","article-title":"VarSelLCM: an R\/C\u2009+\u2009+\u2009package for variable selection in model-based clustering of mixed-data with missing values","volume":"35","author":"Marbac M","year":"2019","unstructured":"Marbac M, Sedki M (2019) VarSelLCM: an R\/C\u2009+\u2009+\u2009package for variable selection in model-based clustering of mixed-data with missing values. Bioinformatics 35:1255\u20131257","journal-title":"Bioinformatics"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/s42003-022-04093-2","article-title":"Multi-level cellular and functional annotation of single-cell transcriptomes using scPipeline","volume":"5","author":"Mikolajewicz N","year":"2022","unstructured":"Mikolajewicz N et al (2022) Multi-level cellular and functional annotation of single-cell transcriptomes using scPipeline. Commun Biology 5:1142","journal-title":"Commun Biology"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41586-023-06130-4","article-title":"Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours","volume":"618","author":"Gavish A","year":"2023","unstructured":"Gavish A et al (2023) Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours. Nature 618:598\u2013606","journal-title":"Nature"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"1800008","DOI":"10.1002\/prca.201800008","article-title":"A comparative proteomics analysis of five body fluids: plasma, urine, cerebrospinal fluid, amniotic fluid, and saliva","volume":"12","author":"Zhao M","year":"2018","unstructured":"Zhao M et al (2018) A comparative proteomics analysis of five body fluids: plasma, urine, cerebrospinal fluid, amniotic fluid, and saliva. PROTEOMICS\u2013Clinical Appl 12:1800008","journal-title":"PROTEOMICS\u2013Clinical Appl"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"549","DOI":"10.21873\/cgp.20280","article-title":"Deep dive on the proteome of human body fluids: a valuable data resource for biomarker discovery","volume":"18","author":"Li Y","year":"2021","unstructured":"Li Y et al (2021) Deep dive on the proteome of human body fluids: a valuable data resource for biomarker discovery. Cancer Genomics Proteomics 18:549\u2013568","journal-title":"Cancer Genomics Proteomics"},{"key":"ref82","article-title":"Large-scale CSF and plasma proteomics reveal immune, synaptic, and extracellular matrix disruptions across neurodegenerative diseases","author":"Ali M","year":"2026","unstructured":"Ali M et al (2026) Large-scale CSF and plasma proteomics reveal immune, synaptic, and extracellular matrix disruptions across neurodegenerative diseases. Neuron","journal-title":"Neuron"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1111\/j.1420-9101.2005.00917.x","article-title":"Combining probability from independent tests: the weighted Z-method is superior to Fisher's approach","volume":"18","author":"Whitlock MC","year":"2005","unstructured":"Whitlock MC (2005) Combining probability from independent tests: the weighted Z-method is superior to Fisher's approach. J Evol Biol 18:1368\u20131373","journal-title":"J Evol Biol"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10480838\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10480838\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T07:45:40Z","timestamp":1786434340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10480838\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":83,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-10480838\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,8,11]]},"subtype":"preprint"}}